Finanças

Discussões Sinais técnicos Sazonais

Lucro Líquido de PRESTIGE BIOPHARMA LIMITED KDR.

Dados anuais

2019

2020

2021

2022

2023

2024

TTM

‪‪−240,00 B‬‬

‪‪−160,00 B‬‬

‪‪−80,00 B‬‬

‪0,00‬

‪‪80,00 B‬‬

Período

Valor

Variação

Variação %

TTM

—

—

—

2024

‪‪−32,95 B‬‬

‪‪−50,54 B‬‬

‪−287,41‬%

2023

‪‪17,58 B‬‬

+‪‪229,18 B‬‬

—

2022

‪‪−211,59 B‬‬

‪‪−204,20 B‬‬

‪‪−2,76 K‬‬%

2021

‪‪−7,39 B‬‬

+‪‪7,61 B‬‬

+‪50,74‬%

2020

‪‪−15,00 B‬‬

‪‪−13,56 B‬‬

‪−936,47‬%

2019

Dados trimestrais

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q1 '25

Q2 '25

‪‪−28,00 B‬‬

‪‪−21,00 B‬‬

‪‪−14,00 B‬‬

‪‪−7,00 B‬‬

‪0,00‬

Período

Valor

Variação

Variação %

Q2 '25

‪‪−13,36 B‬‬

‪‪−7,58 B‬‬

‪−130,98‬%

Q1 '25

‪‪−5,78 B‬‬

‪‪−4,34 B‬‬

‪−299,57‬%

Q3 '24

‪‪−1,45 B‬‬

+‪‪11,58 B‬‬

+‪88,89‬%

Q2 '24

‪‪−13,03 B‬‬

‪‪−3,89 B‬‬

‪−42,58‬%

Q1 '24

‪‪−9,14 B‬‬

‪‪−421,10 M‬‬

‪−4,83‬%

Q4 '23

‪‪−8,72 B‬‬

+‪‪5,11 B‬‬

+‪36,97‬%

Q3 '23

‪‪−13,83 B‬‬

+‪‪10,38 B‬‬

+‪42,89‬%

Q2 '23

‪‪−24,22 B‬‬

‪‪−83,62 B‬‬

‪−140,76‬%

Q1 '23

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21